Haemonetics reports Q4 and FY2023 results; specific figures not available

HAEMONETICS CORP

2023-FY EPS reported $2.24 revenue$1,168,660,000

Reported financial results for quarter and fiscal year ended April 1, 2023.
Press release issued on May 11, 2023, but no financial details provided in filing.
Unable to extract revenue, EPS, or segment performance from available text.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HAEMONETICS CORP reported financial results for the fourth quarter and fiscal year ended April 1, 2023.

Period: the fourth quarter and fiscal year ended April 1, 2023
Result: reported results

Exact text from the filing

On May 11, 2023 , Haemonetics Corporation issued a press release announcing financial results for the fourth quarter and fiscal year ended April 1, 2023.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

HAEMONETICS CORP filing history →

Source: SEC EDGAR

accession 0000313143-23-000010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.